Connect with us

Government

Could an Oregon lawsuit legalize interstate marijuana commerce before Congress?

Published

on

If not Congress, what about the courts?

A not-too-distant future in which marijuana companies can ship products across state lines – if not “legally,” at least without interference from federal or state authorities – is possible if a recently filed lawsuit challenging Oregon state law is successful, legal analysts told MJBizDaily.

Such an outcome might require legal challenges in other states, however.

Also, it would likely require finding other states – and businesses there – willing to accept out-of-state marijuana.

In this way, legalizing interstate commerce via the courts, ahead of outright federal legalization, is a long shot, a sort of Rube Goldberg machine of interdependent hypotheticals that all must fall into place before a single pound is shipped.

But best of all for a marijuana industry tired of delayed federal reform and struggling with tumbling wholesale prices, neither Congress nor the president would have to do anything.

No differently than any other product’

On Nov. 17, a licensed Oregon distribution company, Jefferson Packing House, filed suit against Oregon Gov. Kate Brown and other state officials.

The suit seeks to overturn a section of Oregon law that prohibits state-licensed operators from shipping marijuana across state lines, arguing that such a prohibition is unconstitutional.

Like some other legacy states in the West, Oregon appears amenable to the idea of supplying other states with sun-grown cannabis.

In 2019, Oregon’s governor signed into law legislation that would lift that prohibition if there are significant changes to federal law, including the legalization of interstate commerce.

But Jefferson Packing House’s lawsuit seeks to get ahead of that and eliminate the restriction on exports – even if there is no action at the federal level.

The suit uses the same argument that helped overturn a state residency requirement for Maine medical marijuana operators earlier this year.

In that case, U.S. District Judge Nancy Torresen of the 1st Circuit Court of Appeals ruled that Maine’s law was a violation of the U.S. Constitution’s dormant commerce clause.

The law, she wrote, “explicitly discriminates against residents of other states and Maine cannot show a legitimate local purpose for the requirement.”

In a Nov. 14 letter to Gov. Brown and other state officials, lawyers for Jefferson Packing House argued that under the dormant commerce clause, states “are prohibited from enacting laws regulating interstate commerce, because it is the exclusive purview of Congress.”

Neither Brown’s office, the Oregon state attorney general nor state cannabis officials responded to MJBizDaily requests for comment.

Citing the Maine case, the Jefferson Packing House lawyers wrote in their letter that “we believe it is likely that a federal court will treat marijuana like hazelnuts and invalidate state laws prohibiting the export of marijuana notwithstanding the fact that it is illegal under federal law.”

“Federal courts are signaling that they’re not going to treat cannabis differently than any other product,” one of the attorneys, Andrew DeWeese, told MJBizDaily in an interview.

‘See what the feds do’

However, even if a judge agrees, and if the ruling isn’t appealed – or, if it is, if the U.S. 9th Circuit Court of Appeals, or, potentially, the U.S. Supreme Court, upholds the ruling – a few more hurdles would need to be cleared.

And that could take time.

For starters, regulators in both Oregon and another state would have to create a “regulatory pathway” for licensed companies to start shipping marijuana.

If they did not do so willingly, that potential Supreme Court ruling could strike down prohibitions, though it’s less clear if such a decision would compel other states to write the necessary regulations.

It’s unclear if they would be required to do so if the export prohibition is struck down or if they would need to be compelled to do so via more legal action.

It’s also unclear how welcoming existing marijuana businesses in the target state would be to new competition.

At that point, “someone with real guts will need to say, ‘OK, I’m sending 100 pounds of weed to another state,’” DeWeese said. “And then we’ll have to see what the feds do.”

It’s a lot of “ifs.” But there’s precedent.

Both the 1st Circuit as well as lower federal courts, in response to a Michigan man’s challenge of residency requirements in equity programs, have agreed that the dormant commerce clause applies to cannabis.

As others, including Supreme Court Justice Clarence Thomas, have pointed out, interstate trade in cannabis currently exists – although it is entirely illegal – and which Congress currently “regulates” via the Controlled Substances Act.

If the Jefferson Packing House challenge were to be greeted by a similar ruling at the 9th Circuit – which oversees much of the West Coast – and then again later at the Supreme Court, where Thomas wrote in a 2021 opinion that “prohibition on intrastate use or cultivation of marijuana may no longer be necessary or proper to support the Federal Government’s piecemeal approach” toward cannabis, other states’ bans on exports could later be overturned.

Skeptics who point out that the U.S. Department of Justice might take exception to a few states testing the federal government’s appetite to crack down on marijuana point out that the existing $33 billion MJ industry also violates U.S. law.

Shipping more marijuana across state lines, only this time with state licenses, and entering the transactions into track-and-trace systems is simply another violation of another federal statute, that, until now, has been seen as an ultimately arbitrary red line.

In any event, as attorney DeWeese stated, with outdoor craft farmers known for producing high-quality product suffering through an extended period of plummeting prices, “we need this in Oregon.”

“Our industry in Oregon needs help,” he added, “and this is an incremental step that can be taken that will hopefully convince some other people to take action, too.”

‘Going to win’

DeWeese’s strategy follows an argument that prominent legal scholars have been making for years.

One of them, Vanderbilt University law professor Robert Mikos, believes “they have a very good case.”

“It’s a straightforward argument,” Mikos told MJBizDaily. “You have a state law that plainly burdens interstate commerce.

“There’s no question about it: Oregon has said that the companies licensed in Oregon can’t ship product out of state. There’s no ambiguity there.”

“The only reason we have to doubt any of this at all, whether the dormant commerce clause applies to this market, is because it’s marijuana,” he said, noting that four federal courts have nonetheless ruled that the commerce clause does apply to cannabis.

“Once you accept that, the outcome is obvious,” he added. “The company is going to win, and this ban on the export of cannabis is going to get struck down.”

At the same time, he warned, the status quo will not change quickly.

More lawsuits, such as challenges forcing other states to open their markets to out-of-state cannabis, might follow.

And even if the markets are open to out-of-state-product, that product would need to be competitive.

That cannabis would also be subject to whatever regulations that state would impose. It could be that packaging and labeling requirements would make importing marijuana impractical.

Importantly, Mikos does not expect federal interference from the Justice Department.

“There’s no appetite in the federal government to prosecute these kinds of cases,” he said.

“As long as you are willing to comply with valid state laws – like don’t sell to minors, and package in the way the state wants you to package your product – as long as you are willing to do that, I don’t think the DOJ is going to be hostile to this.

“It’ll be expensive and time-consuming, so things aren’t going to change overnight. Even if we got a ruling tomorrow from the district court saying Oregon’s ban is unconstitutional, it’ll take some time to work out.”

Note of caution

Legal interstate trade would be welcome news to Mike Getlin, who owns and operates Old Apple Farm, a cannabis cultivation operation in Oregon City.

“It would clearly be a huge benefit to almost all Oregon cannabis business,” said Getlin, who is also the founder and president of the Oregon Industry Progress Association.

Getlin and his colleagues have been focused on the plight of cultivators ever since the market for outdoor flower in the state crashed under the weight of epic oversupply, as Oregon’s relatively low costs and permissive rules encouraged cultivators to grow more than they could sell.

Were barriers to shipping to fall, “I don’t think you’ll have any trouble finding someone” willing to test the waters, he said.

“Thousands of people have been shipping weed to the East Coast for 50 years.”

However, partly because of the interest, Getlin is more circumspect and injects a note of caution.

“I’m not sure that it’s necessarily the one solution that a lot of people think it might be,” he said.

Interstate commerce doesn’t fix problems with taxation, with Section 280E of the tax code, or with cannabis businesses unable to claim normal bankruptcy protections or take advantage of tax breaks offered to other agricultural operations, Getlin observed.

And oversupply is not just an Oregon problem.

“We’re seeing a lot of the same pricing realities play out in markets across the country as they mature,” Getlin said.

“While I think it’s a critical step – and one that Oregon businesses have been hoping and preparing for for the better part of a decade now – I think it’s one more step in the right direction and not a solution for all our woes.”

And lawsuits that end up at the Supreme Court are measured in years – time that not every struggling business in the cannabis industry has to spare.

“The trouble is, there’s a lot of good people with good businesses who are going to fail while the government moves at its usual slow pace.”

Source: https://mjbizdaily.com/could-oregon-lawsuit-legalize-interstate-marijuana-commerce-before-congress/

Corruption

Vigilance Arrests Officials After Bribery Complaints at Supply Office

Published

on

By

HARIDWAR, Uttarakhand — Officials from the Dehradun-based Vigilance Department have arrested Haridwar District Supply Officer Shyam Arya and two other employees on charges of accepting a bribe of ₹50,000, authorities confirmed. The arrests took place during a planned operation after investigators laid a trap at the District Supply Office in response to repeated complaints from the public.

According to vigilance sources, the accused were caught “red-handed” while receiving the alleged bribe, reportedly demanded in exchange for official services within the department. The operation, coordinated from the state capital of Dehradun, underscores the department’s commitment to tackling corruption.

Complaints That Triggered the Operation
The arrests followed months of complaints alleging that officials at the Haridwar District Supply Office were routinely soliciting illegal payments for government services. These included the issuance of ration cards, approvals for licenses, and other administrative clearances under the public distribution system.

Vigilance officials said preliminary verification of the complaints indicated a recurring pattern rather than isolated incidents. Following this assessment, the department used a standard anti-corruption tactic of laying a trap to obtain direct evidence of bribe solicitation and acceptance.

Inside the Supply Office
After the arrests, vigilance teams established a presence inside the office, sealing parts of the premises while examining files and records. Investigators are reviewing documentation related to recent approvals and transactions to determine whether the alleged bribery was systemic.

The accused are also being questioned to identify potential accomplices and to ascertain whether accepting bribes was a routine practice. Officials noted that the investigation could expand depending on findings from the document review and interrogations.

A Broader Anti-Corruption Push
The case has drawn attention across Uttarakhand’s administrative machinery, particularly within the Supply Department, which plays a vital role in delivering welfare services. Vigilance officials said the arrests reflect a “zero-tolerance” approach toward corruption and warned that similar operations will continue wherever credible complaints arise.

The state’s anti-corruption drives have intensified in recent months, emphasizing both deterrence and accountability. While the investigation in Haridwar remains in its early stages, officials say it highlights the risks faced by public servants accused of exploiting their positions and the growing willingness of enforcement agencies to act on citizen complaints.

Continue Reading

Business

A Tipping Point for Cannabis: President Trump Champions CBD & Cannabis Science on Truth Social

Published

on

By

When the President of the United States shares a video about the life changing potential of hemp derived CBD on his personal social media platform, it is more than news, it is a cultural shift.

For decades our government lied to us about cannabis. It demonized the plant, waged war on its users, and filled prisons while allowing pharmaceutical companies to flood the nation with addictive and deadly drugs. For over a century we have been fighting uphill, not just for legalization, but for truth, for science, and for the right to heal ourselves naturally.

Now in 2025, the most powerful political figure on Earth is using his own voice and platform to talk about the endocannabinoid system and the science backed benefits of CBD. That is monumental. It is validation for everyone who has fought, been arrested, been silenced, and been dismissed for telling this truth. The President’s video post is already being described as a pivotal moment in cannabis history, and President Trump CBD Cannabis Science Truth Social is trending across platforms as advocates celebrate the breakthrough.


The Science Behind the Endocannabinoid System

The video begins by introducing something most people, including many doctors, still know little about, the endocannabinoid system. Discovered in the 1990s, the ECS is a network of receptors and signaling molecules that works as the body’s master regulator, coordinating communication between major systems like the nervous, immune, cardiovascular, and digestive systems.

The roots of this discovery go back much further. CBD was first isolated in 1940 by American chemist Roger Adams, but it was Dr. Raphael Mechoulam, an Israeli organic chemist, who fully elucidated the chemical structure of CBD and identified its stereochemistry in the 1960s. His pioneering work not only opened the door to modern cannabinoid science but also earned him the title “Godfather of Cannabis Research.” It was this foundation that led to the identification of the endocannabinoid system itself decades later, revealing how cannabinoids interact with our physiology on a fundamental level.

The ECS is now widely recognized as a vital part of human biology, with extensive research supported by the National Institutes of Health. When functioning properly, the ECS acts like the conductor of an orchestra, ensuring every section plays in harmony. As we age, the system weakens. That imbalance is linked to inflammation, chronic pain, cognitive decline, sleep problems, and many other conditions associated with aging.

Mainstream medicine often addresses these issues with pharmaceutical band aids, dangerous and addictive drugs that treat symptoms rather than root causes. Lifestyle changes such as diet and exercise help, but they only partially support the ECS and do so slowly over time.


Hemp Derived CBD: A Game Changer for Aging

Here is where the science gets exciting. As the video explains, the ECS can be restored much more quickly with hemp derived CBD. Strengthening this system naturally helps the body regain balance, reducing pain, improving sleep, lowering stress, slowing disease progression, and even extending healthy lifespan.

It is not theoretical. One in five seniors is already using CBD to manage pain, arthritis, cancer symptoms, sleep disorders, Alzheimer’s, and more. Despite decades of research and acknowledgment from institutions like the National Institutes of Health, most physicians receive no training on the ECS. There are still no FDA standards for CBD products on the market. If that were the case for any other class of medicine, it would be considered malpractice.

The World Health Organization has confirmed CBD’s excellent safety profile and non addictive nature in its critical review report. The result is that millions of older Americans are suffering unnecessarily when a safe and natural solution exists.

Hemp derived CBD is a powerful first step in restoring balance to the endocannabinoid system, but it is only part of the picture. Research shows that full spectrum cannabis extracts, which include a broader range of cannabinoids and terpenes, can work even more effectively. Complete concentrated cannabis oil, containing the full spectrum of natural endocannabinoids, may deliver the most profound results for certain patients. Expanding access to these therapies will be essential if we want to unlock the full healing potential of this plant.


The Economic and Social Impact

The video cites a powerful figure. A PricewaterhouseCoopers analysis estimates that fully integrating cannabis into the healthcare system could save the United States nearly 64 billion dollars annually. These savings reflect reduced pharmaceutical dependency, fewer hospitalizations, improved chronic disease outcomes, and enhanced quality of life for aging Americans. You can read more about PwC’s research on healthcare innovation here.

It is a financial argument, but it is also a moral one. Why should our elders endure pain, anxiety, and cognitive decline when nature has given us tools to help them live longer, happier, and healthier lives?


A Call to Action: Finish What the Farm Bill Started

The message concludes by crediting the 2018 Farm Bill, championed by President Trump, for legalizing hemp and laying the groundwork for today’s CBD market. The Farm Bill was just the first step.

Now the call is for bold next moves.

  • Educate doctors about the endocannabinoid system
  • Include CBD under Medicare coverage
  • Provide clear federal standards for CBD quality and dosing

These steps would constitute the most significant senior health reform in modern history, one that would transform aging and cement a powerful legacy for any administration that makes it happen.


What This Means for Future Cannabis Medicine

For those of us who have been in the cannabis community for decades, this is not just another news story. It is a signal that our movement is winning. A conversation that was once criminalized and censored is now being amplified by the President of the United States on his own platform.

It means the science is undeniable. It means the truth can no longer be buried. It means the wall of prohibition is cracking, not just legally, but culturally, scientifically, and politically.

It also means that everything we have been fighting for at 420 Magazine since 1993, education, access, healing, and justice, is finally moving full steam ahead. The President Trump CBD Cannabis Science Truth Social moment is proof that science and policy are finally converging.

Continue Reading

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News